Global Covid-19 Vaccination Market 2022-2026

Global Covid-19 Vaccination Market 2022-2026

Technavio has been monitoring the covid-19 vaccination market and the growth is expected to reduce by $ 68.35 bn during 2022-2026, progressing at a CAGR of (36.56)% during the forecast period. Our report on the covid-19 vaccination market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of COVID-19 infection and favorable government initiatives. In addition, the increasing incidence of COVID-19 infection is anticipated to boost the growth of the market as well.

The covid-19 vaccination market analysis includes the application segment and geographic landscape.

Technavio's covid-19 vaccination market is segmented as below:

By Application

• mRNA
• others

By Geographical Landscape

• North America
• Asia
• Europe
• ROW

This study identifies the rising awareness about efficient vaccinationas one of the prime reasons driving the COVID-19 vaccination market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on COVID-19 vaccination market covers the following areas:

• COVID-19 vaccination market sizing
• COVID-19 vaccination market forecast
• COVID-19 vaccination market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading COVID-19 vaccination market vendors that include AstraZeneca Plc, Bharat Biotech Ltd., China National Pharmaceutical Group Corp., Gamaleya National Center, Inovio Pharmaceuticals Inc., Johnson and Johnson Inc., Moderna Inc., Novavax Inc., Pfizer Inc., and Sinovac Biotech Ltd. Also, the COVID-19 vaccination market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.